{"schema_version":"1","generated_at":"2026-11-08T12:45:16.399Z","data_as_of":"2026-11-08","url":"https://www.findmykol.com/kol/benjamin-besse","json_url":"https://www.findmykol.com/kol/benjamin-besse/profile.json","record_kind":"full","profile_kind":"research","person":{"slug":"benjamin-besse","name":"Benjamin Besse","credential":"MD","title":"Director of Clinical Research, Gustave Roussy","specialty":"Medicine","therapeutic_area":"Lung","therapeutic_areas":["Lung"],"institution":"Gustave Roussy","institution_url":"https://www.findmykol.com/institution/gustave-roussy","country":{"name":"France","code":"FR","status":"provisional"},"register":{"label":"licensed_physician","kind":"rpps","id":"10004030994","country":"FR","specialty":"Oncologie option médicale","hospital":"INSTITUT GUSTAVE ROUSSY SITE VILLE JUIF","as_of":"2026-10-19"}},"identifiers":{"orcid":"0000-0001-5090-8189","openalex":"A5023794502","rpps":"10004030994"},"summary":"Benjamin Besse is Director of Clinical Research, Gustave Roussy at Gustave Roussy. OpenAlex indexes 1,599 publications with 58,741 citations (h-index 102); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.","overview":{"text":"Benjamin Besse is Director of Clinical Research, Gustave Roussy. The public record shows 1,599 publications with 58,741 citations (h-index 102), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 13 registered clinical trials.","bullets":["Most recent indexed publication: 2026 · Cancer discovery","Top research focus: Lung Cancer Treatments and Mutations","13 registered trials on ClinicalTrials.gov"],"generated_at":"2026-11-08"},"focus":{"indications":[{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":7,"topics":0,"strength":22},{"label":"Small Cell Lung Carcinoma","therapeutic_area":"Oncology","trials":5,"topics":0,"strength":15},{"label":"Carcinoma, Small Cell","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Thymoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Melanoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":4},{"label":"Mesothelioma, Malignant","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Mesothelioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Thymic epithelial tumor","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Bladder / Urothelial Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Prostate Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Viral Hepatitis (B/C)","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1},{"label":"IBS / Functional GI","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1},{"label":"Myasthenia Gravis","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Chronic Kidney Disease","therapeutic_area":"Nephrology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Kidney Cancer / RCC","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Rheumatoid Arthritis","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Acromegaly","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Idiopathic Pulmonary Fibrosis","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"Lupus (SLE)","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Pancreatic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"MDS / MPN","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Atrial Fibrillation","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Tuberculosis","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"COPD","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1}],"research_topics":["Lung Cancer Treatments and Mutations","Lung Cancer Diagnosis and Treatment","Cancer Immunotherapy and Biomarkers","Lung Cancer Research Studies","Cancer Genomics and Diagnostics"],"works_with":{"total":9,"shown":3,"withheld":6,"rows":[{"name":"Intergroupe Francophone de Cancerologie Thoracique","trials":3,"payments":0,"mentions":3},{"name":"European Organisation for Research and Treatment of Cancer - EORTC","trials":2,"payments":0,"mentions":2},{"name":"Gustave Roussy, Cancer Campus, Grand Paris","trials":2,"payments":0,"mentions":2}]}},"scholarship":{"works_count":1599,"cited_by_count":58741,"h_index":102,"i10_index":540,"pubmed_count":56,"latest_activity_year":2026,"source":"works"},"trials":{"count":13,"shown":3,"withheld":10,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT05692999","title":"Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study","phase":"PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","source_url":"https://clinicaltrials.gov/study/NCT05692999"},{"nct":"NCT04710628","title":"Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"MedSIR","source_url":"https://clinicaltrials.gov/study/NCT04710628"},{"nct":"NCT04289259","title":"Tumor Mutational Burden in Lung Cancer Patients","status":"TERMINATED","role":"Investigator","sponsor":"Assistance Publique - Hôpitaux de Paris","source_url":"https://clinicaltrials.gov/study/NCT04289259"}],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":474,"years":{"first":2005,"last":2026},"societies":["AACR","ASCO","ASH","ASTRO","ESMO","ESTRO Congress","IASLC","ISPOR Europe"],"shown":3,"withheld":471,"rows":[{"title":"Abstract 2434: Prognostic and predictive effects of TP53 co-mutations and RET fusion partners in RET -rearranged advanced NSCLC","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-2434","source_url":"https://doi.org/10.1158/1538-7445.am2026-2434","status":"verified"},{"title":"Abstract 6472: Tumor-cell NY-ESO-1 expression predicts poor response to PD-1/PD-L1 blockade in NSCLC","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-6472","source_url":"https://doi.org/10.1158/1538-7445.am2026-6472","status":"verified"},{"title":"Abstract 7047: Characterization of TKI-induced drug-tolerant persister cells from patient-derived cell lines.","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-7047","source_url":"https://doi.org/10.1158/1538-7445.am2026-7047","status":"verified"}],"source":"congress"},"publications":{"total":56,"shown":5,"withheld":51,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Targeting KRAS Codon 13 Mutations Using Direct Combination Approaches in Non-Small Cell Lung Cancer.","year":2026,"journal":"Cancer discovery","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42329102/","status":"verified"},{"title":"Spatial transcriptomics identifies tumor-intrinsic and stromal programs associated with immune exclusion in NSCLC.","year":2026,"journal":"Signal transduction and targeted therapy","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42966824/","status":"verified"},{"title":"Second- and third-line outcomes after selective RET inhibitor failure in RET fusion-positive metastatic lung cancer: A real-world analysis from the RET-MAP registry.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42873584/","status":"verified"},{"title":"Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42456046/","status":"verified"},{"title":"Role of ctDNA Tumor Fraction in Selecting Immunotherapy-Based Regimens in Advanced Non-Small Cell Lung Cancer.","year":2026,"journal":"Clinical cancer research : an official journal of the American Association for Cancer Research","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42440365/","status":"verified"}],"source":"publications"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD, PhD","source_url":"https://targetedonc.com/authors/benjamin-besse-md-phd","status":"provisional","collected_at":"2026-11-08"}]},"roles":{"total":2,"shown":2,"rows":[{"value":"President, European Organisation for Research and Treatment of Cancer (EORTC) (2026-present)","source_url":"https://www.eortc.org/blog/2026/06/26/benjamin-besse-eortc-president/","status":"verified","collected_at":"2026-11-08"},{"value":"President-Elect, European Organisation for Research and Treatment of Cancer (EORTC) (2025-2026)","source_url":"https://oncodaily.com/blog/professor-benjamin-besse-named-president-319709","status":"provisional","collected_at":"2026-11-08"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"Hubertus-Wald Award (2022)","source_url":"https://esmo.org/about-esmo/biographies/benjamin-besse","status":"provisional","collected_at":"2026-11-08"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"Professor of Medical Oncology, Paris-Saclay University","source_url":"https://www.universite-paris-saclay.fr/en/news/benjamin-besse-deeper-understanding-thoracic-cancers","status":"provisional","collected_at":"2026-11-08"}]},"media":{"total":2,"shown":2,"rows":[{"value":"Profile feature: Benjamin Besse, MD, PhD chooses a career in medicine over music (ASCO Post, September 2023)","source_url":"https://ascopost.com/issues/september-10-2023/benjamin-besse-md-phd-chooses-a-career-in-medicine-over-music/","status":"provisional","collected_at":"2026-11-08"},{"value":"Spotlight on Lung Cancer: Interview with Benjamin Besse (EORTC blog, 2018)","source_url":"https://www.eortc.org/blog/2018/02/01/spotlight-on-lung-cancer-interview-with-benjamin-besse/","status":"provisional","collected_at":"2026-11-08"}]}},"similar":[{"name":"David Planchard","slug":"david-planchard","institution":"Gustave Roussy","url":"https://www.findmykol.com/kol/david-planchard","json_url":"https://www.findmykol.com/kol/david-planchard/profile.json"},{"name":"Ignacio Wistuba","slug":"ignacio-wistuba","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ignacio-wistuba","json_url":"https://www.findmykol.com/kol/ignacio-wistuba/profile.json"},{"name":"Pasi Janne","slug":"pasi-janne","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/pasi-janne","json_url":"https://www.findmykol.com/kol/pasi-janne/profile.json"},{"name":"Julie Brahmer","slug":"julie-brahmer","institution":"Johns Hopkins University School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/julie-brahmer","json_url":"https://www.findmykol.com/kol/julie-brahmer/profile.json"},{"name":"Enriqueta Felip","slug":"enriqueta-felip","institution":"Vall d'Hebron Institute of Oncology (VHIO)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/enriqueta-felip","json_url":"https://www.findmykol.com/kol/enriqueta-felip/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":10,"congress":471,"publications":51}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-08"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-08"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-08"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-08"}},"methodology_url":"https://www.findmykol.com/about#methodology"}